Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

Wilmington PharmaTech ("WPT"), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has ...

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its ...

DURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO") ...

A July report by a team of Jefferies analysts paints an upbeat picture for contract development and manufacturing organizations (CDMOs). Miyabi Yamakita and colleagues reported rising demand for the ...

SARASOTA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has entered into a ...

Thermo Fisher Scientific says addressing the need for prefilled syringes is among potential production bottlenecks, the company is working to address. Thermo Fisher’s Accelerator™ Drug Development ...

The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the ...

This investment comes as LGM Pharma experiences sustained growth in prescription drug projects, including 505(b)(2) and Abbreviated New Drug Application (ANDA) programs. The Rosenberg facility ...